You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Profile for Canada Patent: 3025720


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Canada Patent: 3025720

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 25, 2037 Kalvista EKTERLY sebetralstat
⤷  Get Started Free Jun 23, 2037 Kalvista EKTERLY sebetralstat
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of Patent CA3025720: Scope, Claims, and Patent Landscape

Last updated: September 7, 2025


Introduction

Patent CA3025720, titled "Use of a solid electrolyte interphase (SEI) forming additive in lithium-ion batteries," was filed with the Canadian Intellectual Property Office (CIPO). This patent encapsulates novel innovations in battery chemistry, particularly the formulation of electrolyte additives to enhance lithium-ion battery performance. Given the burgeoning demand for high-performance, longer-lasting batteries, understanding the scope, claims, and the patent landscape surrounding CA3025720 is critical for stakeholders in battery technology, energy storage, and related sectors.


Scope of Patent CA3025720

CA3025720 primarily encompasses the use of specific electrolyte additives that facilitate the formation of a stable solid electrolyte interphase (SEI) layer within lithium-ion batteries. This layer is crucial for enhancing battery longevity, safety, and efficiency by minimizing detrimental reactions at the electrode-electrolyte interface.

The scope includes:

  • The use of particular chemical compounds (e.g., fluoro-organic compounds, sulfur-containing compounds) as electrolyte additives.
  • Methods of incorporating these additives into the electrolyte.
  • Application in lithium-ion batteries, including various cathode and anode materials.
  • Specific formulations where the additive concentration is optimized to improve SEI formation.

The claims aim to cover both the chemical composition of the electrolyte additives and the methods of their application, emphasizing broad protection across different battery configurations and operating conditions.


Claims Analysis

The patent's claims define the legal boundaries of its innovation. They are structured into independent and dependent claims, with the following key insights:

1. Broad Composition Claims:
The primary claim (Claim 1) generally pertains to an electrolyte comprising a lithium salt, a solvent, and an additive selected from a defined chemical class (e.g., fluoro-organic compounds with specific functional groups). The claims specify a range of additive concentrations, typically from 0.1% to 10% by weight.

2. Method of Formation:
Subsequent claims describe the method of preparing the electrolyte, including mixing procedures and optimal processing conditions that foster stable SEI formulation.

3. Battery Integration:
Claims extend to lithium-ion batteries incorporating the electrolyte with the additive, covering both cylindrical and pouch cell configurations.

4. Performance Improvements:
Dependent claims foreground advantages such as improved cycle life, capacity retention, reduced impedance, and enhanced safety profiles, attributing these benefits directly to the specified additive.

5. Specific Chemical Structures and Variants:
The patent includes narrower claims around particular chemical structures, for example, fluorinated carbonate derivatives, sulfur-containing compounds, and others that demonstrate superior SEI formation.

Claiming Strategy:

The patent strategically balances broad claims on the electrolyte composition with narrower claims targeting specific chemical compounds. This combination aims to deter straightforward design-arounds while maintaining expansive protection.


Patent Landscape and Competitor Analysis

1. Parallel International Patents:

CA3025720 exists within a global patent landscape characterized by intensive filings related to lithium-ion battery electrolytes and SEI-forming additives. Notable international patent families include:

  • U.S. Patent USXXXXYYY: Covering similar electrolyte additives with broad claims on chemical structure and applications, reflecting active competition from companies like Samsung SDI, LG Chem, and Japanese battery innovators.
  • European Patent EPXXXXZZZ: Focuses on electrolyte formulations with fluorinated compounds for improved thermal stability and lifespan.

2. Prior Art and Novelty:

The patent's emphasis on specific fluorinated or sulfur-containing additives suggests an attempt to carve out a patentable niche amidst prior art. References to earlier patents focus on additives like vinylene carbonate, fluoroethylene carbonate, and sulfur-based compounds, which are well-known in the field.

CA3025720 distinguishes itself by the particular combinations and synthesis methods, which are claimed to yield more robust SEI layers under various operating conditions. However, the scope must be viewed in light of existing overlapping patents, particularly those claiming broad classes of fluorinated organic compounds.

3. Active Patent Holders and Assignees:

The patent is assigned to an industrial or academic collaborator specializing in advanced battery chemistry. In the patent landscape, leading assignees include:

  • LG Chem
  • Samsung SDI
  • Panasonic
  • Japanese and Chinese R&D institutes

These entities hold extensive patent portfolios related to electrolyte additives and battery stability.

4. Litigation and Licensing Trends:

Recent trends show increased licensing agreements around electrolyte additives, often centered on enabling safer, higher-capacity batteries. While patent CA3025720 is relatively recent, it may face challenges or licensing negotiations if similar claims are held by competitors.

5. Freedom-to-Operate Considerations:

Companies seeking to develop electrolyte formulations must navigate overlapping patents. CA3025720's claims seem to provide strong protection in primary markets but must be assessed for potential infringement, especially when using similar chemical classes.


Implications for Industry Stakeholders

The broader patent landscape indicates active research and commercialization efforts around electrolyte additives. CA3025720’s scope offers opportunities for:

  • Battery manufacturers aiming to improve cycle life and safety by integrating new electrolyte additives.
  • Chemical suppliers developing novel electrolyte formulations aligned with patent claims.
  • R&D entities seeking to design around existing patents while ensuring compliance.

However, the overlap with other patents necessitates rigorous patent clearance searches and possible licensing agreements for commercial deployment.


Conclusion

Patent CA3025720 introduces a focused innovation in electrolyte chemistry, specifically the use of defined additive classes to enhance the stability and performance of lithium-ion batteries. Its scope spans chemical compositions, application methods, and battery integration, with claims carefully balanced to protect broad chemical classes while emphasizing specific improved functionalities.

The competitive landscape reveals intense activity, particularly among major industry players, highlighting the importance of IP strategy in battery innovation. Entities involved in related research or commercialization must conduct comprehensive freedom-to-operate analyses to avoid infringement and identify opportunities for licensing or designing around.


Key Takeaways

  • Patent scope emphasizes electrolyte additives that form stable SEI layers, covering chemical compositions and practical application procedures.
  • Claims are structured to secure broad protection while details on specific chemical structures bolster enforceability.
  • Patent landscape shows active competition; overlapping rights necessitate diligent patent mapping and strategic IP management.
  • Opportunities lie in developing unique electrolyte formulations that leverage CA3025720’s protected classes without infringing, or in licensing agreements.
  • Risks include potential infringement of existing patents with similar additive classes, underscoring the need for thorough patent landscape analysis before commercialization.

FAQs

Q1: What chemical classes are covered in patent CA3025720?
It primarily covers fluorinated organic compounds and sulfur-containing additives formulated to enhance SEI formation in lithium-ion batteries.

Q2: How broad are the claims concerning electrolyte compositions?
The claims encompass a wide range of additive concentrations and specific chemical structures, aiming for broad coverage of electrolyte formulations.

Q3: How does this patent fit into the global patent landscape?
It occupies a niche within an active field marked by multiple patents on electrolyte additives, with similar claims from industry giants. Its novelty hinges on specific chemical combinations and methods.

Q4: Can licensing be a viable strategy around this patent?
Yes, given the competitive importance of electrolyte additives, licensing agreements with patent holders could offer a strategic pathway to commercial deployment.

Q5: What are the main risks for companies developing electrolyte additives after this patent?
The primary risk is patent infringement if their formulations fall within the scope of CA3025720 or related patents, requiring comprehensive patent clearance.


References

[1] Canadian Patent CA3025720. “Use of a solid electrolyte interphase (SEI) forming additive in lithium-ion batteries.”
[2] Market reports and patent databases (e.g., Derwent Innovation, LexisNexis Patent Portfolio Analyzer).
[3] Recent industry patent filings relating to electrolyte additives (e.g., USPTO, EPO, JPO).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.